Latest KFF Health News Content

Latest KFF Health News Stories

Virginia Reports First Child Death From MIS-C

Morning Briefing

On Friday Virginia health officials confirmed that an individual identified as being between the ages of 10 and 19 died of the inflammatory syndrome associated with covid. News outlets cover Virginia’s plans to track covid in sewage, L.A. county mask plans, and more.

UK Calls G7 Meeting Over Omicron; Peru Has Worst Covid Death Rate

Morning Briefing

As omicron hits the world, news outlets cover calls for vaccinating everyone on the planet, a rapid surge in cases in two major South African cities, and the highest covid death rate: In Peru, where it’s officially killed 6,000 out of every million people.

Health Industry Braces For More Worker Losses, Winter Covid Surge

Morning Briefing

Hospitals and care facilities are preparing for a round of health worker resignations, driven by the Jan. 4 federal vaccine mandate deadline. Meanwhile, the pandemic’s toll on cancer doctors and contract tracers is also in the news.

Fauci Vs. His Republican Critics

Morning Briefing

Dr. Anthony Fauci is firing back at Republicans like Senator Ted Cruz, who have attacked him. In other news from the nation’s capital, the NIH director says it may be two or three weeks before scientists know enough about the new variant and the Supreme Court hearing an abortion case and a 340B case.

FDA Says Merck’s Anti-Covid Pill Works

Morning Briefing

The Food and Drug Administration said the experimental covid drug treatment was effective against the virus. Merck said it reduces hospitalization risks by 30%. But ongoing work is needed to determine its safety for use during pregnancy, including for risk of birth defects.

Researchers Begin To Work On Omicron, Investigate Symptoms

Morning Briefing

The newest concerning variant of covid is alarming researchers, and forcing politician’s hands, but some early evidence suggests its symptoms may be mild. Vaccine makers are working out their responses, but Moderna says it could be ready in early 2022.

Omicron Hits Canada, Is Popping Up Globally Despite Travel Bans

Morning Briefing

On Sunday, Canada’s health minister said two cases of the new variant had been confirmed. Britain has more cases, and a flight in the Netherlands was found to have brought many cases from South Africa. The World Health Organization has, however, urged against travel bans.

White House Stresses Shots And Boosters In Response To Omicron Variant

Morning Briefing

Vaccination remains a “key weapon” in the face of the new omicron covid “variant of concern,” officials said. President Joe Biden is expected to speak on the matter today, and has been told it may take up to two weeks for scientists to come up with definitive answers and new advice.

Juul Settles Lawsuit For Allegedly Marketing To Young People In Arizona

Morning Briefing

The e-cigarette maker will pay out $14.5 million in the settlement. Separately, Florida’s Supreme Court rejected a $5 million damages suit against tobacco maker R.J. Reynolds over the death of a smoker in 2007.

WHO: Europe May See Over 2 Million Covid Deaths By Spring

Morning Briefing

News outlets report on the WHO’s warnings over surging covid in some European countries, with Germany considering a full lockdown. Meanwhile, a little-known cult in South Korea is reportedly a source of a new outbreak.

200 Homicide Total In D.C. Is Highest In 18 Years

Morning Briefing

Meanwhile, Procter & Gamble recalled some Old Spice and Secret antiperspirant sprays after contaminating benzene was found, San Francisco declared a water shortage emergency, and reports highlight 10 million people who are uninsured could still qualify for public marketplace health.

Covid Proves More Deadly To Psychiatric Patients, Racial Minorities

Morning Briefing

Two new studies highlight the higher death risks from covid infections for racial minorities and patients with schizophrenia and other mood disorders (despite fewer infections). Meanwhile, an Israeli drug, called the “only cure for late-stage covid,” shows promise in trials.